<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-28355" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part indexed="no" book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Renal Failure (Archived)</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bindroo</surname>
            <given-names>Sandiya</given-names>
          </name>
          <aff>Crozer Chester MC/Drexel University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Quintanilla Rodriguez</surname>
            <given-names>Bryan S.</given-names>
          </name>
          <aff>New York Medical College - Metropolitan Hospital Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Challa</surname>
            <given-names>Hima J.</given-names>
          </name>
          <aff>Cape Fear Valley Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sandiya Bindroo declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bryan Quintanilla Rodriguez declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Hima Challa declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>24</day>
          <month>9</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-28355.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The term renal failure denotes the inability of the kidneys to perform excretory function leading to retention of nitrogenous waste products from the blood. Functions of the kidney are&#x000a0;as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Electrolyte and volume regulation</p>
          </list-item>
          <list-item>
            <p>Excretion of nitrogenous waste</p>
          </list-item>
          <list-item>
            <p>Elimination of exogenous molecules, for example, many drugs</p>
          </list-item>
          <list-item>
            <p>Synthesis of a variety of hormones, for example, erythropoietin</p>
          </list-item>
          <list-item>
            <p>Metabolism of low molecular weight proteins, for example, insulin</p>
          </list-item>
        </list>
        <p>Acute and chronic renal failure are the two kinds of kidney failure.</p>
        <p>
<bold>Acute Renal Failure (ARF)</bold>
</p>
        <p>ARF is the syndrome in which glomerular filtration declines abruptly (hours to days) and is usually reversible. According to the KDIGO criteria in 2012, AKI can be diagnosed with&#x000a0;any one of the following: (1) creatinine increase of 0.3 mg/dL in 48 hours, (2) creatinine increase to 1.5 times baseline within last 7 days, or (3) urine volume less than 0.5 mL/kg per hour for 6 hours.&#x000a0;<xref ref-type="bibr" rid="article-28355.r1">[1]</xref>&#x000a0;Recently the term acute kidney injury (AKI) has replaced ARF because AKI denotes the entire clinical spectrum from a mild increase in serum creatinine to overt renal failure.&#x000a0;<xref ref-type="bibr" rid="article-28355.r2">[2]</xref></p>
        <p>
<bold>Chronic Renal Failure&#x000a0;(CRF)</bold>
</p>
        <p>CRF or chronic kidney disease (CKD) is defined as a persistent impairment of kidney function, in other words, abnormally elevated serum creatinine for more than 3 months or calculated glomerular filtration rate (GFR) less than 60 ml per minute / 1.73m2. It often involves a progressive loss of kidney function necessitating renal replacement therapy (dialysis or transplantation). When a patient needs renal replacement therapy, the condition is called end-stage renal disease (ESRD).&#x000a0;<xref ref-type="bibr" rid="article-28355.r1">[1]</xref></p>
        <p>CKD classified based on grade:</p>
        <list list-type="bullet">
          <list-item>
            <p>Grade 1: GFR greater than 90</p>
          </list-item>
          <list-item>
            <p>Grade 2: 60 to 89</p>
          </list-item>
          <list-item>
            <p>Grade 3a: 45 to 59</p>
          </list-item>
          <list-item>
            <p>Grade 3b: 30 to 44</p>
          </list-item>
          <list-item>
            <p>Grade 4: 15 to 29</p>
          </list-item>
          <list-item>
            <p>Grade 5: Less than 15</p>
          </list-item>
        </list>
        <p>CKD classified based on stage:</p>
        <list list-type="bullet">
          <list-item>
            <p>Stage 1: GFR greater than 90</p>
          </list-item>
          <list-item>
            <p>Stage 2: 60 to 89</p>
          </list-item>
          <list-item>
            <p>Stage 3: 30 to 59</p>
          </list-item>
          <list-item>
            <p>Stage 4: 15 to 29</p>
          </list-item>
          <list-item>
            <p>Stage 5: Less than 15</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28355.s2" sec-type="Etiology">
        <title>Etiology</title>
        <p>
<bold>Renal Failure Etiopathogenesis</bold>
</p>
        <p>
<italic toggle="yes">
<bold>Acute Renal Failure&#x000a0;<xref ref-type="bibr" rid="article-28355.r3">[3]</xref></bold>
</italic>
</p>
        <list list-type="order">
          <list-item>
            <p><italic toggle="yes">Prerenal </italic>(approximately 60%): Hypotension, volume contraction (e.g., sepsis, hemorrhage), severe organ failure such as heart failure or liver failure, drugs like non-steroidal anti-inflammatory drugs (NSAIDs), angiotensin receptor blockers (ARB) and angiotensin-converting enzyme inhibitors (ACEI), and cyclosporine</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Intrarenal </italic>(approximately 35%): Acute tubule necrosis (from prolonged prerenal failure, radiographic contrast material, drugs like aminoglycosides, or nephrotoxic substances), acute interstitial nephritis (drug-induced), connective tissue disorders (vasculitis), arteriolar insults, fat emboli, intrarenal deposition (seen in tumor-lysis syndrome, increased uric acid production and multiple myeloma-Bence-Jones proteins), rhabdomyolysis</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Postrenal </italic>(approximately 5%): Extrinsic compression (prostatic hypertrophy, carcinoma), intrinsic obstruction (calculus, tumor, clot, stricture), decreased function (neurogenic bladder)</p>
          </list-item>
        </list>
        <p>
<bold>
<italic toggle="yes">Chronic Renal Failure&#x000a0;<xref ref-type="bibr" rid="article-28355.r4">[4]</xref></italic>
</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Diabetes mellitus, especially type 2 diabetes mellitus, is the most frequent cause of ESRD.</p>
          </list-item>
          <list-item>
            <p>Hypertension is the second most frequent cause.</p>
          </list-item>
          <list-item>
            <p>Glomerulonephritis</p>
          </list-item>
          <list-item>
            <p>Polycystic kidney diseases</p>
          </list-item>
          <list-item>
            <p>Renal vascular diseases</p>
          </list-item>
          <list-item>
            <p>Other known causes, like prolonged obstruction of the urinary tract, nephrolithiasis</p>
          </list-item>
          <list-item>
            <p>Vesicoureteral reflux, a condition in which urine backs up into the kidneys</p>
          </list-item>
          <list-item>
            <p>Recurrent kidney infections/ pyelonephritis</p>
          </list-item>
          <list-item>
            <p>Unknown etiology</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28355.s3" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The incidence of AKI has been cited as 1% on hospital admission, 2% to 5% during hospitalization, and in as many as&#x000a0;37% of patients treated in intensive care units (ICUs), and in 4% to 15% of patients after cardiovascular surgery.&#x000a0;<xref ref-type="bibr" rid="article-28355.r5">[5]</xref>&#x000a0;<xref ref-type="bibr" rid="article-28355.r6">[6]</xref>&#x000a0;<xref ref-type="bibr" rid="article-28355.r7">[7]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Overall, the incidence of AKI has been estimated to be 209 patients per million population per year, with 36% of patients with AKI requiring renal replacement therapy.&#x000a0;<xref ref-type="bibr" rid="article-28355.r7">[7]</xref></p>
          </list-item>
          <list-item>
            <p>The incidence and prevalence of CRF in the United States are uncertain. The third National Health and Nutrition Examination Survey (NHANES III) shows that almost 2 million people in the United States have a serum creatinine level of 2 mg/dl or greater.&#x000a0;<xref ref-type="bibr" rid="article-28355.r8">[8]</xref></p>
          </list-item>
          <list-item>
            <p>CRF is known to be more prevalent in men than in women. This gender disparity extends to ESRD.</p>
          </list-item>
          <list-item>
            <p>ESRD develops in over 100,000 persons a year in the United States.&#x000a0;<xref ref-type="bibr" rid="article-28355.r7">[7]</xref>,&#x000a0;<xref ref-type="bibr" rid="article-28355.r8">[8]</xref></p>
          </list-item>
          <list-item>
            <p>Rates of ESRD vary with race. Both the incidence and prevalence of ESRD are three to four times higher in Black patients than in White patients.<xref ref-type="bibr" rid="article-28355.r8">[8]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28355.s4" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Renal failure pathophysiology can be described by a sequence of events that happen while during acute insult in the setting of acute renal failure and also gradually over a period in cases of chronic kidney diseases.</p>
        <p>Broadly, AKI can be classified into three groups:&#x000a0;<xref ref-type="bibr" rid="article-28355.r9">[9]</xref></p>
        <list list-type="order">
          <list-item>
            <p>The decrease in renal blood flow (prerenal azotemia):&#x000a0;Prerenal AKI occurs secondary to either an absolute reduction in extracellular fluid volume or a reduction in circulating volume despite a normal total fluid volume, e.g., in advanced cirrhosis, heart failure, and sepsis. Normally kidney auto-regulatory mechanisms maintain intra-capillary pressure during the initial phase by causing dilation of afferent arterioles and constriction of efferent arterioles. When prerenal conditions become severe, renal adaptive mechanisms fail to compensate, unmasking the fall in GFR and the increase in BUN and creatinine levels.</p>
          </list-item>
          <list-item>
            <p>Intrinsic renal parenchymal diseases (renal azotemia): Intrinsic disorders can be subdivided into those involving the glomeruli, vasculature, or tubulointerstitium respectively.</p>
          </list-item>
          <list-item>
            <p>Obstruction of urine outflow (postrenal azotemia)</p>
          </list-item>
        </list>
        <p>The pathophysiology of CRF is related mainly to specific initiating mechanisms. Over the course of&#x000a0;time, adaptive physiology leads to compensatory hyperfiltration and hypertrophy of remaining viable nephrons. As insults continue, histopathologic changes occur, including distortion of glomerular architecture, abnormal podocyte function, and disruption of filtration, leading to sclerosis.&#x000a0;<xref ref-type="bibr" rid="article-28355.r10">[10]</xref></p>
      </sec>
      <sec id="article-28355.s5" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The relevant history and physical examination findings associated with renal failure include:</p>
        <p>
<italic toggle="yes">History</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Detailed history of present illness</p>
          </list-item>
          <list-item>
            <p>Medical history such as diabetes mellitus, hypertension</p>
          </list-item>
          <list-item>
            <p>A family history of kidney diseases</p>
          </list-item>
          <list-item>
            <p>Review of hospital records</p>
          </list-item>
          <list-item>
            <p>Previous renal function</p>
          </list-item>
          <list-item>
            <p>Medications, especially start date, drug levels of nephrotoxic agents, NSAIDs</p>
          </list-item>
          <list-item>
            <p>Any use of a contrast agent or any procedure performed</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Physical examination</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Hemodynamics, including blood pressure, heart rate, weight</p>
          </list-item>
          <list-item>
            <p>Volume status to look for edema, jugular venous distention, lung crackles, and S3 gallop</p>
          </list-item>
          <list-item>
            <p>Skin: check for any diffuse rash or uremic frost</p>
          </list-item>
          <list-item>
            <p>Look for signs of uremia: asterixis, lethargy, seizures, pericardial friction rub, peripheral neuropathies</p>
          </list-item>
          <list-item>
            <p>Abdomen exam: check for bladder distention, note any suprapubic fullness</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28355.s6" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Patients with renal failure have a variety of different clinical presentations as explained in the history and physical exam section. Many patients are asymptomatic and are incidentally found to have an elevated serum creatinine concentration, abnormal urine studies (such as proteinuria or microscopic hematuria), or abnormal radiologic imaging of the kidneys.&#x000a0;The key laboratory and imaging studies to be ordered in patients with renal failure include the following.</p>
        <p>
<bold>Laboratory Tests</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Urinalysis, dipstick, and microscopy&#x000a0; &#x000a0;</p>
          </list-item>
        </list>
        <list list-type="order">
          <list-item>
            <p>Dipstick for blood and protein; microscopy for cells, casts, and crystals</p>
          </list-item>
          <list-item>
            <p>Casts: Pigmented granular/muddy brown casts-ATN; WBC casts-acute interstitial nephritis; RBC casts-glomerulonephritis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Urine electrolytes</p>
          </list-item>
        </list>
        <p>Fractional excretion of sodium (FENa) = [(UNa x PCr)/ (PNa x UCr)] x 100, where U is urine, P is plasma, Na is sodium, andCr is Creatinine. If FeNa less than 1, then likely prerenal; greater than 2, then likely intrarenal; greater than 4, then likely postrenal</p>
        <p>If the patient is on diuretics, use FEurea instead of FENa. Complete blood count, BUN, creatinine (Cr), arterial blood gases (ABGs) may also be sent.</p>
        <list list-type="bullet">
          <list-item>
            <p>Calculate Cr clearance to ensure that medications are dosed appropriately:&#x000a0;Cockcroft-Gault equation Cr clearance (mL/min) = (140-age) x (weight in kilograms) x (0.85 if female)/(72 x serum creatinine)</p>
          </list-item>
        </list>
        <p>
<bold>Special Labs</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Creatinine Kinase (CK)</p>
          </list-item>
          <list-item>
            <p>Immunology antibodies based on the clinical scenario</p>
          </list-item>
        </list>
        <p>
<bold>Imaging</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Renal ultrasound (US)</p>
          </list-item>
          <list-item>
            <p>Doppler-flow kidney US, depending upon the clinical scenario</p>
          </list-item>
          <list-item>
            <p>An abdominal x-ray (KUB) to evaluate for renal calculi (not all calculi will be present on KUB)</p>
          </list-item>
        </list>
        <p>More advanced imaging techniques should be considered if initial tests do not reveal etiology:</p>
        <list list-type="bullet">
          <list-item>
            <p>Radionucleotide renal scan, CT scan,&#x000a0;and/or MRI</p>
          </list-item>
          <list-item>
            <p>Cystoscopy with retrograde pyelogram</p>
          </list-item>
          <list-item>
            <p>Kidney biopsy</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28355.s7" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment options for renal failure vary widely and depend on the cause of failure. Broadly, options are divided into two groups: treating the cause of renal failure in acute states versus replacing the renal function in acute situations and chronic conditions. Below is the summary of renal failure treatment.</p>
        <p>
<bold>Acute Renal Failure</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>The mainstay is treating the underlying cause and associated complications</p>
          </list-item>
          <list-item>
            <p>If the case of oliguria and no volume overload is noted, a fluid challenge may be appropriate with diligent monitoring for volume overload</p>
          </list-item>
          <list-item>
            <p>In the case of hyperkalemia with ECG changes, IV calcium, sodium bicarbonate, and glucose with insulin should be given. These measures drive potassium into cells and can be supplemented with polystyrene sulfonate, which removes potassium from the body. Hemodialysis is also an emergency method of removal.</p>
          </list-item>
          <list-item>
            <p>If acidosis is present, serum bicarbonate intravenous or oral versus emergency/urgent dialysis based on the clinical situation</p>
          </list-item>
          <list-item>
            <p>If obstructive etiology presents treat accordingly. Bladder outlet obstruction secondary to prostatic hypertrophy may benefit from Flomax or other selective alpha-blockers</p>
          </list-item>
        </list>
        <p>
<bold>
<italic toggle="yes">General Measures</italic>
</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Always review the drug list.</p>
          </list-item>
          <list-item>
            <p>Stop nephrotoxic drugs and renally adjust others. Many supplements not approved by the FDA can be nephrotoxic.</p>
          </list-item>
          <list-item>
            <p>Always record ins and outs.</p>
          </list-item>
          <list-item>
            <p>Monitor daily weights.</p>
          </list-item>
          <list-item>
            <p>Watch for complications, including hyperkalemia, pulmonary edema, and acidosis wich are potential reasons to start dialysis.</p>
          </list-item>
          <list-item>
            <p>Ensure good cardiac output and subsequent renal blood flow.</p>
          </list-item>
          <list-item>
            <p>In terms of diet, total caloric intake should be 35 to 50 kcal/kg per day to avoid catabolism. Potassium intake should be restricted to 40 mEq per day; phosphorus should be restricted to 800 mg per day. Hyperphosphatemia can treated with calcium carbonate or other phosphate binder. Magnesium compounds should be avoided.</p>
          </list-item>
          <list-item>
            <p>Treat infections aggressively.</p>
          </list-item>
        </list>
        <p>
<bold>
<italic toggle="yes">Immediate Dialysis Indications</italic>
</bold>
<italic toggle="yes">&#x000a0;</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Severe hyperkalemia</p>
          </list-item>
          <list-item>
            <p>Acidosis</p>
          </list-item>
          <list-item>
            <p>Volume overload refractory to conservative therapy</p>
          </list-item>
          <list-item>
            <p>Uremic pericarditis</p>
          </list-item>
          <list-item>
            <p>Encephalopathy</p>
          </list-item>
          <list-item>
            <p>Alcohol and drug intoxications</p>
          </list-item>
        </list>
        <p>
<bold>Chronic Renal Failure</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Optimize control of specific causes of CKD, such as diabetes mellitus and hypertension.</p>
          </list-item>
          <list-item>
            <p>Measure sequentially and plot the rate of decline in GFR in all patients</p>
          </list-item>
          <list-item>
            <p>Any acceleration in the rate of decline should prompt a search for a superimposed acute or subacute process that may be reversible.</p>
          </list-item>
          <list-item>
            <p>Rule out extracellular fluid volume depletion, uncontrolled hypertension, urinary tract infection, new obstructive uropathy, exposure to nephrotoxic agents (such as NSAIDs or contrast dye), reactivation or flare of the original disease such as lupus or vasculitis</p>
          </list-item>
        </list>
        <p>Interventions to slow the progression of CKD include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Reducing intra-glomerular filtration</p>
          </list-item>
          <list-item>
            <p>Reducing proteinuria; effective meds include ACE/ARB</p>
          </list-item>
          <list-item>
            <p>Strict glycemic control</p>
          </list-item>
          <list-item>
            <p>Preventing and treating complications of CKD</p>
          </list-item>
          <list-item>
            <p>Discuss renal replacement therapy with patients appropriately.</p>
          </list-item>
          <list-item>
            <p>Periodically review medications and avoid nephrotoxic medicines.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Patients with CKD should be referred to a nephrologist when eGFR is less than 30 ml per minute, as this provides enough time for adequate preparation for kidney replacement therapy.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28355.s8" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Acute kidney injury</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Alport Syndrome</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Antiglomerular basement membrane disease</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>hronic glomerulonephritis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Diabetic neuropathy</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Multiple Myeloma</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Nephrolithiasis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Nephrosclerosis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28355.s9" sec-type="Complications">
        <title>Complications</title>
        <list list-type="bullet">
          <list-item>
            <p>Volume overload</p>
          </list-item>
          <list-item>
            <p>Hyponatremia</p>
          </list-item>
          <list-item>
            <p>Hyperkalemia</p>
          </list-item>
          <list-item>
            <p>Metabolic acidosis</p>
          </list-item>
          <list-item>
            <p>Calcium and phosphate balance</p>
          </list-item>
          <list-item>
            <p>Anemia</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28355.s10" sec-type="Consultations">
        <title>Consultations</title>
        <list list-type="order">
          <list-item>
            <p>Consult&#x000a0;nephrology&#x000a0;in all cases where&#x000a0;the patient has a drop in urine output with elevated creatinine.</p>
          </list-item>
          <list-item>
            <p>Urology consultation for obstructive nephropathies, relief of obstruction with retrograde ureteral catheters, or percutaneous nephrostomy.</p>
          </list-item>
          <list-item>
            <p>Surgical or interventional radiology consults for placement of hemodialysis catheter.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28355.s11" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <list list-type="bullet">
          <list-item>
            <p>The typical FeNa values for each type of AKI: Pre-renal: Less than 1%; Intrinsic renal greater than 2%; Post-renal: Greater than 4%</p>
          </list-item>
          <list-item>
            <p>The typical BUN/creatinine ratios for each type of AKI: Pre-renal greater than 20:1; Intrinsic renal Less than 10:1; Post-renal or normal 10 to 20:1.</p>
          </list-item>
          <list-item>
            <p>Patients who get diuretics may have a higher urinary concentration of sodium due to the diuretic, falsely elevating the fractional excretion of sodium. In these patients, use the fractional excretion of urea (FeUrea) instead since it is relatively unaffected by diuretics.</p>
          </list-item>
          <list-item>
            <p>Serum creatinine which is used as a marker of kidney function is also affected by muscle mass (lower muscle mass causes falsely low serum creatinine).</p>
          </list-item>
          <list-item>
            <p>The Modification of Diet in Renal Disease&#x000a0;(MDRD)&#x000a0;formula includes age, gender, race, BUN, creatinine, and albumin. These are&#x000a0;all important factors in measuring kidney function (GFR) and all automatically printed in lab reports.</p>
          </list-item>
          <list-item>
            <p>Prevention of AKI begins before hospitalization by obtaining a nephrology consultation appropriately in patients with CKD 3, CKD 4, and CKD 5.</p>
          </list-item>
          <list-item>
            <p>Adjust doses of medications according to the estimated glomerular filtration rate (GFR).</p>
          </list-item>
          <list-item>
            <p>Watch for hyperkalemia while taking simultaneous ACEI or ARB/spironolactone in patients with CKD.</p>
          </list-item>
          <list-item>
            <p>Check for bone mineral disorders in patients with CKD.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28355.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The management of kidney failure is usually done with an interprofessional team of healthcare professionals dedicated to preserving renal function. Kidney failure has enormous morbidity and mortality, costing the healthcare system billions of dollars each year. Today, many hospitals have a kidney failure nurse who educates patients on the causes, detection, and prevention of kidney failure. The pharmacist also needs to audit patient medications for those that are nephrotoxic regularly. When monitoring patients with kidney failure, the nurse should note the urine output, levels of potassium, blood sugar and creatinine. Control of blood pressure and blood sugar is vital in the prevention of kidney disease. The diabetic nurse should closely monitor the renal function of all diabetics and refer patients to the nephrologist if the renal function is deteriorating. The pharmacist should emphasize the importance of medication compliance for the treatment of blood pressure. These patients should have close follow up to ensure that renal function is not deteriorating. Finally, the patient needs to be given advice on healthy eating, exercise, discontinuing tobacco and abstaining from alcohol. Kidney disease is not well managed can lead to complete renal failure, which requires dialysis.<xref ref-type="bibr" rid="article-28355.r11">[11]</xref><xref ref-type="bibr" rid="article-28355.r12">[12]</xref>&#x000a0;Open communication between the team members can reduce the morbidity and mortality of renal failure.</p>
        <p>
<bold>Outcomes</bold>
</p>
        <p>Recovery from acute renal failure depends on the cause of the disease. If the cause is reversible, the prognosis is good and leans toward a full recovery. Partial recovery of renal function may occur if the injury does not fully resolve. Severe cases of acute renal failure can result in death.&#x000a0;</p>
        <list list-type="order">
          <list-item>
            <p>The prognosis for hospitalized patients with AKI depends largely&#x000a0;on the site (ICU or floor).</p>
          </list-item>
          <list-item>
            <p>AKI patients are at increased risk for progressing into CKD during their lifetime.</p>
          </list-item>
          <list-item>
            <p>CKD is correlated with high morbidity and mortality. Cardiovascular mortality is 10 to 30 times higher in ESRD patients treated with dialysis compared to those in the general population. <xref ref-type="bibr" rid="article-28355.r13">[13]</xref><xref ref-type="bibr" rid="article-28355.r14">[14]</xref>(Level V)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28355.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28355&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28355">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/28355/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=28355">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-28355.s14">
        <title>References</title>
        <ref id="article-28355.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chertow</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Burdick</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Honour</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bonventre</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Bates</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>Acute kidney injury, mortality, length of stay, and costs in hospitalized patients.</article-title>
            <source>J Am Soc Nephrol</source>
            <year>2005</year>
            <month>Nov</month>
            <volume>16</volume>
            <issue>11</issue>
            <fpage>3365</fpage>
            <page-range>3365-70</page-range>
            <pub-id pub-id-type="pmid">16177006</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28355.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Luo</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Xi</surname>
                <given-names>X</given-names>
              </name>
              <collab>Beijing Acute Kidney Injury Trial (BAKIT) workgroup</collab>
            </person-group>
            <article-title>A comparison of different diagnostic criteria of acute kidney injury in critically ill patients.</article-title>
            <source>Crit Care</source>
            <year>2014</year>
            <month>Jul</month>
            <day>08</day>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>R144</fpage>
            <pub-id pub-id-type="pmid">25005361</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28355.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Friedman</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Acute renal failure.</article-title>
            <source>N Engl J Med</source>
            <year>1996</year>
            <month>Oct</month>
            <day>24</day>
            <volume>335</volume>
            <issue>17</issue>
            <fpage>1321; author reply 1321</fpage>
            <page-range>1321; author reply 1321-2</page-range>
            <pub-id pub-id-type="pmid">8992331</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28355.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Calderon-Margalit</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Golan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Twig</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Leiba</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tzur</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Afek</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Skorecki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Vivante</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>History of Childhood Kidney Disease and Risk of Adult End-Stage Renal Disease.</article-title>
            <source>N Engl J Med</source>
            <year>2018</year>
            <month>Feb</month>
            <day>01</day>
            <volume>378</volume>
            <issue>5</issue>
            <fpage>428</fpage>
            <page-range>428-438</page-range>
            <pub-id pub-id-type="pmid">29385364</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28355.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bagshaw</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>George</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bellomo</surname>
                <given-names>R</given-names>
              </name>
              <collab>ANZICS Database Management Committe</collab>
            </person-group>
            <article-title>A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients.</article-title>
            <source>Nephrol Dial Transplant</source>
            <year>2008</year>
            <month>May</month>
            <volume>23</volume>
            <issue>5</issue>
            <fpage>1569</fpage>
            <page-range>1569-74</page-range>
            <pub-id pub-id-type="pmid">18281319</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28355.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaufman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dhakal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hamburger</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Community-acquired acute renal failure.</article-title>
            <source>Am J Kidney Dis</source>
            <year>1991</year>
            <month>Feb</month>
            <volume>17</volume>
            <issue>2</issue>
            <fpage>191</fpage>
            <page-range>191-8</page-range>
            <pub-id pub-id-type="pmid">1992662</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28355.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Correa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chauhan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Saha</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dave</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Poojary</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mishra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Annapureddy</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Dalal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Konstantinidis</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Nimma</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nadkarni</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pinney</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>National Trends and Outcomes in Dialysis-Requiring Acute Kidney Injury in Heart Failure: 2002-2013.</article-title>
            <source>J Card Fail</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>24</volume>
            <issue>7</issue>
            <fpage>442</fpage>
            <page-range>442-450</page-range>
            <pub-id pub-id-type="pmid">29730235</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28355.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garg</surname>
                <given-names>AX</given-names>
              </name>
              <name>
                <surname>Kiberd</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Haynes</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Clase</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III.</article-title>
            <source>Kidney Int</source>
            <year>2002</year>
            <month>Jun</month>
            <volume>61</volume>
            <issue>6</issue>
            <fpage>2165</fpage>
            <page-range>2165-75</page-range>
            <pub-id pub-id-type="pmid">12028457</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28355.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lindner</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sherrard</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Acute renal failure.</article-title>
            <source>N Engl J Med</source>
            <year>1996</year>
            <month>Oct</month>
            <day>24</day>
            <volume>335</volume>
            <issue>17</issue>
            <fpage>1320</fpage>
            <page-range>1320-1; author reply 1321-2</page-range>
            <pub-id pub-id-type="pmid">8992330</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28355.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Almirall</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Sodium Excretion, Cardiovascular Disease, and Chronic Kidney Disease.</article-title>
            <source>JAMA</source>
            <year>2016</year>
            <month>Sep</month>
            <day>13</day>
            <volume>316</volume>
            <issue>10</issue>
            <fpage>1112</fpage>
            <pub-id pub-id-type="pmid">27623468</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28355.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ghimire</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Banks</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jose</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Castelino</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Zaidi</surname>
                <given-names>STR</given-names>
              </name>
            </person-group>
            <article-title>Medication adherence assessment practices in dialysis settings: A survey of renal nurses' perceptions.</article-title>
            <source>J Clin Nurs</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>28</volume>
            <issue>3-4</issue>
            <fpage>528</fpage>
            <page-range>528-537</page-range>
            <pub-id pub-id-type="pmid">30091498</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28355.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Soragna</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bermond</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fabbrini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rodofili</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Soragna</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bauducco</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Panunzi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ramondetti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cerri</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vitale</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>[The "Nephrology outpatient Triage": an organizational model for the ambulatory care of patients with advanced renal disease].</article-title>
            <source>G Ital Nefrol</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>35</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">29582964</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28355.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goswami</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pahwa</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Vohra</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Raju</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>Clinical spectrum of hospital acquired acute kidney injury: A prospective study from Central India.</article-title>
            <source>Saudi J Kidney Dis Transpl</source>
            <year>2018</year>
            <season>Jul-Aug</season>
            <volume>29</volume>
            <issue>4</issue>
            <fpage>946</fpage>
            <page-range>946-955</page-range>
            <pub-id pub-id-type="pmid">30152434</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28355.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Park</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Paek</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Chin</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Na</surname>
                <given-names>KY</given-names>
              </name>
              <name>
                <surname>Chae</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Awareness, incidence and clinical significance of acute kidney injury after non-general anesthesia: A retrospective cohort study.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>97</volume>
            <issue>35</issue>
            <fpage>e12014</fpage>
            <pub-id pub-id-type="pmid">30170408</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
